酸可以通过激活AMPK/SREBP2/PCSK9/LDL受体信号通路来改善高脂血症
Jing Feng1, Run Xu1, Zijia Dou1
1State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Pharmacology, College of Pharmacy, and Department of Cardiology, the Second Affiliated Hospital, Harbin Medical University, Harbin, 150081, China; State Key Labratoray-Province Key Laboratories of Biomedicine-Pharmaceutics of China, and Key Laboratory of Cardiovascular Research, Ministry of Education, College of Pharmacy, Harbin, 150081, China; Research Unit of Noninfectious Chronic Diseases in Frigid Zone (2019RU070), Chinese Academy of Medical Sciences, Harbin, 150081, China.
水 (THBru) 通过激活AMP激活蛋白激酶 (AMPK) 有效地治疗高脂血症. 这种化合物调节关键的脂质代谢通路,为管理高胆固醇水平提供了一个有前途的新疗法策略.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 代谢疾病 代谢疾病
背景情况:
- 超脂血是心血管疾病的重要危险因素,需要新的治疗干预措施.
- 柏柏林的衍生物四柏柏鲁 (THBru) 显示出改善的生物利用性和降低的毒性.
- 在治疗高脂血症方面,THBru的治疗潜力在很大程度上仍未被探索.
研究的目的:
- 调查THBru在改善高脂血症方面的疗效.
- 阐明THBru对脂质代谢作用的潜在分子机制.
主要方法:
- 使用高脂肪饮食建立了一个超脂血症小鼠模型.
- 评估了THBru对肝损伤和脂质配置文件的影响.
- 分子对接,CETSA和细胞测试被用来识别分子点和途径.
主要成果:
- 在超脂症小鼠中,THBru的使用显著缓解了肝损伤,并纠正了脂质代谢障碍.
- 证实了THBru和AMP激活蛋白激酶 (AMPK) 之间的直接相互作用.
- THBru调节了AMPK/SREBP2/PCSK9/LDL受体通路,影响了脂质调节.
结论:
- THBru作为AMPK的潜在激动剂,改善高脂血症.
- THBru调节SREBP2/PCSK9/LDL受体通路,提供一种新的脂质管理机制.
- 这项研究为THBru作为超脂血症的潜在治疗剂提供了新的见解.
相关概念视频
cAMP-dependent Protein Kinase Pathways
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Receptor-mediated Endocytosis
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cholesterol: Significance and Regulation
Considering cholesterol and...


